CBS News Staffers on the Verge of Revolt If This Person Is Hired
He Served 27 Years In Prison for a Murder He Didn't Commit. Now...
Washingtonian Food Editor Says Trump Should Stay Out of D.C. Restaurants
Ron DeSantis' 'Deportation Depot' Is Open for Business, and More Are Coming
Amy Coney Barrett Shoots Down Those Claiming America Is in a 'Constitutional Crisis'
Trump Blames Powell for Weak Jobs Report, Demands Fed Rate Cuts
Inside the 'War Room' Hunting America’s Lost Immigrant Children
Newsom Aims to Sidestep Federal Authority, Sets Up 'West Coast Health Alliance'
South Korea Protests After More Than 300 Nationals Arrested in Hyundai Factory Raid
Blame It on the Kaine
Court Reveals Which Items Were Seized During FBI Raid of Bolton’s Home
Polls Show Strong Approval for President Trump As Second Term Gains Momentum
Trump Reverses Biden-Harris H-2A Visa Rules to Ease Farmer Burdens, Boost Rural Economy
Feds Seize Record-Breaking Chemical Haul Meant for Cartel
It's Been an Ugly Week for Failed Democratic VP Nominees Named Tim
Tipsheet

We're Already Seeing the Effects of Trump Nominating RFK Jr. to HHS

AP Photo/Ross D. Franklin

Vaccine stocks are continuing to fall after President-elect Donald Trump announced he would nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 

Advertisement

“We have a generational opportunity to bring together the greatest minds in science, medicine, industry, and government to put an end to the chronic disease epidemic,” Kennedy said in a statement Thursday after Trump nominated him.  

At 1204 GMT, shares in Britain's GSK (GSK.L), opens new tab were down 3.2% at their lowest in more than a year, while AstraZeneca and France's Sanofi (SASY.PA), opens new tab were down between 2.6% and 2.8% respectively. [...]

Sartorius (SATG.DE), opens new tab, a major supplier of biotech lab gear and substances, fell 3.8%.

Bavarian Nordic (BAVA.CO), opens new tab, which makes a vaccine for mpox, was down 16%, also hurt by third-quarter results

The Danish biotech firm's CEO voiced concerns that RFK Jr, as he is known, could fuel vaccine scepticism but also told Reuters that the U.S. response to the COVID-19 pandemic during Trump's first term made him confident about future bio-defence funding by the incoming U.S. administration.

German-listed shares of BioNtech (22UAy.DE), opens new tab, Pfizer's partner on COVID-19 vaccines, were down more than 10%, set for their biggest one-day fall since August.  [...]

In premarket trading, U.S. vaccine makers fell further after Thursday's declines, with Moderna (MRNA.O), opens new tab down 2.21% after hitting its lowest since April 2020 on Thursday and Novavax (NVAX.O), opens new tab 1.94% lower. 

Pfizer (PFE.N), opens new tab was marginally lower after falling to April lows a day earlier. (Reuters

Advertisement

"For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health," Trump said in a statement announcing Kennedy as his pick to lead HHS. "The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country. Mr. Kennedy will restore these Agencies to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!"

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement